Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy.
Dagan N, Barda N, Biron-Shental T, Makov-Assif M, Key C, Kohane IS, Hernán MA, Lipsitch M, Hernandez-Diaz S, Reis BY, Balicer RD.
.
COVID-19 mRNA vaccination leading to CNS inflammation: a case series.
Khayat-Khoei M, Bhattacharyya S, Katz J, Harrison D, Tauhid S, Bruso P, Houtchens MK, Edwards KR, Bakshi R.
.
.
Soluble urokinase-type plasminogen activator receptor is over-expressed in uterine endometrium from women with endometriosis.
Sillem M, Prifti S, Monga B, Buvari P, Shamia U, Runnebaum B.
. Free PMC article.
.
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial.
Marconi VC, Ramanan AV, de Bono S, Kartman CE, Krishnan V, Liao R, Piruzeli MLB, Goldman JD, Alatorre-Alexander J, de Cassia Pellegrini R, Estrada V, Som M, Cardoso A, Chakladar S, Crowe B, Reis P, Zhang X, Adams DH, Ely EW; COV-BARRIER Study Group.
.